Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2005
08/04/2005US20050170406 Using Burkitt's lymphoma-172 nucleotide sequences as diagnostic, prognostic and imaging tool in detection and treatment of infection and cell proliferative disorders of urogenital system
08/04/2005US20050170398 Producing three or more non-identical antibodies in a single recombinant host cell in which a nucleic acid sequence encoding a light chain and nucleic acid sequences encoding different heavy chains are expressed
08/04/2005US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay
08/04/2005US20050170382 Immunoglobulin comprising receptor for advanced glycation endproducts for treating inflammation; antiinflammtory agents
08/04/2005US20050170381 Using lymphocytes expressing jun kinase as tools in detecting modulators for treatment of cell proliferative disorders
08/04/2005US20050170380 Ribosomal protein for treatment, diagnosis and prevention of cell proliferative, atherosclerotic and nervous system disorders
08/04/2005US20050170374 Expression vector comprising nucleotide sequences coding protein factor for treatment, diagnosis and prevention of proliferative and differentiative disorders
08/04/2005US20050170368 Tumor-associated antigenic target polypeptides for use as tools in treatment of cell proliferative disorders; antitumor and/or antiproliferative agents
08/04/2005US20050170344 Chds as modifiers of the p53 pathway and methods of use
08/04/2005US20050170334 Human monoclonal antibodies to influenza M2 protein and methods of making and using same
08/04/2005US20050170333 Identification of etiology of autism
08/04/2005US20050169932 Uses of monoclonal antibody 8h9
08/04/2005US20050169931 EphA2 as a therapeutic target for cancer
08/04/2005US20050169930 PSCA: prostate stem cell antigen and uses thereof
08/04/2005US20050169929 Utilizing tumor associated antigen, epitope, mimotope, specific or antiidiotypic antibody in combination with chemotherapy; kits
08/04/2005US20050169928 Antibodies which bind to proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes
08/04/2005US20050169927 Human tissue factor antibodies
08/04/2005US20050169926 DNA sequence encoding an antibody fusion protein which is useful for the treatment and diagnosis of various cancers, including colon cancer; anticarcinogenic agents; biodrugs
08/04/2005US20050169925 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
08/04/2005US20050169924 BAFF, inhibitors thereof and their use in the modulation of B-cell response
08/04/2005US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
08/04/2005US20050169922 drug screening for compounds that enhance or suppress killer T cell activity by contacting killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
08/04/2005US20050169920 Pecam-1 modulation
08/04/2005US20050169919 DNA encoding the amino acid sequence fusion protein; regulate T cell interactions with B7 positive cells, immune responses; treating tissue transplant rejection, graft versus host disease with immunomodulator; antiproliferative agent of lymphocyte
08/04/2005US20050169918 selectively targeting; screening an effect of a Chemokine receptor (CCR4) modulating agent; adjusting the adhesion of T cells to endothelial cells; treating inflammatory skin disease; side effect reduction without affecting on other cells
08/04/2005US20050169916 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
08/04/2005US20050169915 selected from heavy chains, light chains and modified variable regions; breast cancer therapy; detecting using antigen and antibody complex; immunoassay, immunotherapy
08/04/2005US20050169914 Novel functions for decay accelerating factor (DAF) in inflammation
08/04/2005US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase
08/04/2005US20050169911 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
08/04/2005US20050169910 monoclonal antibody binds to TcII for inhibiting cellular uptake of vitamin B12 resulting in apoptosis; antitumor agents
08/04/2005US20050169909 polypeptide inducing an immunological response; making a monoclonal antibody allergy, by immunizing an animal with the polypeptide; antibody is used to treat asthma, allergic rhinitis, atopic dermatis, urticaria, or eczema; antiallergens; biodrugs
08/04/2005US20050169907 amino acid sequence peptide is derived from the N' terminus region of the 50 Kd subunit of heparanase; used in drug screening for antibody as enzyme inhibitors; antitumor agents, anticarcinogenic agents, antiinflammatory agents; autoimmune disease and kidney urogenital disorder
08/04/2005US20050169901 controlling cytokine levels by administering extract or secreted products from microorganism; biosynthesis; atheroma, degenerative vascular disease or cardiovascular disease associated with inflammation of the coronary arteries; hypotensive agents, antilipemic agents, anticholesterol agents
08/04/2005US20050169889 Immunogenic agent therapy using plasmapheresis or exchange transfusion
08/04/2005US20050169870 Methods of modulating CD200
08/04/2005US20050169853 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis
08/04/2005CA2554585A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
08/04/2005CA2554472A1 Lawsonia intracellularis subunit vaccines
08/04/2005CA2553883A1 Anti-cancer antibodies with reduced complement fixation
08/04/2005CA2553731A1 Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell
08/04/2005CA2553456A1 Primary central nervous system tumor specific behab isoforms
08/04/2005CA2552882A1 Methods for diagnosis and prognosis of cancers of epithelial origin
08/04/2005CA2552788A1 Fc region variants
08/04/2005CA2550551A1 Fusion polypeptides capable of activating receptors
08/03/2005EP1560026A1 Methods of detecting collagen degradation
08/03/2005EP1560025A2 Specific markers for diabetes
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559725A1 Antigen recognizing antibody
08/03/2005EP1558766A2 Use of a33 antigens and jam-it
08/03/2005EP1558749A2 Atypical protein kinase c isoforms in disorders of the nervous system and cancer
08/03/2005EP1558741A2 Recombination of nucleic acid library members
08/03/2005EP1558731A2 Modified hepsin molecules having a substitute activation sequence and uses thereof
08/03/2005EP1558650A2 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
08/03/2005EP1558649A1 Peptides modulating caspase activation
08/03/2005EP1558648A2 Human monoclonal antibodies against cd20
08/03/2005EP1558647A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/03/2005EP1558646A2 Single domain antibodies directed against interferon- gamma and uses thereof
08/03/2005EP1558645A2 Stabilized single domain antibodies
08/03/2005EP1558644A2 A structured peptide scaffold for displaying turn libraries on phage
08/03/2005EP1558642A1 Chimeric cytoplasmic signalling molecules
08/03/2005EP1558640A2 Trimeric binding proteins for trimeric cytokines
08/03/2005EP1558631A2 Methods and compositions for diagnosing and treating companion animal cancer
08/03/2005EP1558286A2 Assay for autoantibodies to folate receptors
08/03/2005EP1558284A1 Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
08/03/2005EP1558280A2 Compositions and methods for treating or preventing pneumococcal infection
08/03/2005EP1558277A1 Treatment of inflammatory bowel disease
08/03/2005EP1558276A2 Flaviviris fusion inhibitors
08/03/2005EP1558275A2 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation
08/03/2005EP1558086A2 Cell targeting methods and compositions
08/03/2005EP1237900A4 Subunit optimized fusion proteins
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
08/03/2005EP1049777B1 Acpl dna and polypeptides
08/03/2005EP1012285B1 Beta-defensins
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0825259B1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005CN1650016A Method for modifying plant morphology, biochemistry and physiology including expression plant fission agent oxidase
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1649903A Rs7抗体 Rs7 antibody
08/03/2005CN1649902A Internalizing anti-CD74 antibodies and methods of use
08/03/2005CN1649901A Specific antibody fragments for the human carcinoembryonic antigen (cea)
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649894A A method for identification, isolation and production of antigens to a specific pathogen
08/03/2005CN1649890A Anti-protozoal vaccine
08/03/2005CN1649626A Use of molecules which interact with the haptoglobin receptor ligand binding
08/03/2005CN1649625A Conjugates of therapeutic or cytotoxic agents and biologically active peptides
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649623A Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
08/03/2005CN1648665A Recombined pronucleus expression detection antigen for detecting goose parvovirus anti-body and preparing method
08/03/2005CN1213141C Heterotrophic medium composition for transgenenic chlorella
08/03/2005CN1213070C Monoclonal antibodies directed against the G3BP protein and use
08/03/2005CN1213069C Growth promoting factor and its prepn and use
08/02/2005US6924412 transgenic, non-human animal with a genome a that has stably integrated, recombinant nucleic acid encoding a polymeric immunoglobulin receptor protein linked to a mammary specific promoter
08/02/2005US6924368 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis
08/02/2005US6924363 use in the separation and recovery of recombinant polypeptides from the cell due to the difference in densities between oil bodies and aqueous solutions
1 ... 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 ... 1494